NEUCHATEL, Svizzera–(BUSINESS WIRE)–Fields (NASDAQ: MASI) today announced the results of a prospective, randomized controlled, double-blind study published in Medicinein which Dr. Jin Hee Ahn and colleagues at Sungkyunkwan University School of Medicine in Seoul, Korea evaluated the ability of Masimo ORi™ to help physicians determine supplemental oxygenation during laparoscopic gastrectomy surgery elective. The researchers observed that the combination of ORi and oxygen saturation (SpO2) standard of care reduced hyperoxemia compared with SpO monitoring alone2.
The original text of this announcement, written in the source language, is the official version which is authentic. Translations are offered solely for the convenience of the reader and must refer to the text in the original language, which is the only legally valid one.
Contacts
Media contact:
Fields
Evan Lamb
949-396-3376
